Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
Approval for generic Semaglutide Injection strengthens CDMO partnership, enabling scalable supply from OneSource’s US FDA-approved Bengaluru facility
The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Subscribe To Our Newsletter & Stay Updated
